By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).

Contact Information

Website: www.immunovant.com
Email: info@immunovant.com
Main Phone: +1 917 580-3099
Address: 320 West 37th Street
Address 2: 3rd Floor
State: NY
City / Town: New York
Country: US
Postal Code: 10018

Issuer Information

Exchange: NGS
CEO: Peter Salzmann
Employees: 42
NAICS: All Other Basic Organic Chemical Manufacturing(325199)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A